![Paul G. Abrams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul G. Abrams
Direttore/Membro del Consiglio presso Geneius Biotechnology, Inc.
Posizioni attive di Paul G. Abrams
Società | Posizione | Inizio | Fine |
---|---|---|---|
Geneius Biotechnology, Inc.
![]() Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Paul G. Abrams
Precedenti posizioni note di Paul G. Abrams
Società | Posizione | Inizio | Fine |
---|---|---|---|
PONIARD PHARMACEUTICALS, INC. | Amministratore Delegato | 01/01/1990 | 31/07/2001 |
Presidente | 01/01/1990 | 31/07/2001 | |
CEPTYR, Inc.
![]() CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Presidente | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
President | 2 |
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
CEPTYR, Inc.
![]() CEPTYR, Inc. Pharmaceuticals: MajorHealth Technology CEPTYR, Inc. developed pharmaceutical products. The company was founded by George Rathmann & Deborah Cool in 1995 and was headquartered in Redmond, WA. | Health Technology |
Geneius Biotechnology, Inc.
![]() Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Geneius Biotechnology, Inc. operates as an immuno-oncology company. It develops autologous, adoptive T cell therapy technology which generates robust immune response to cancer. The company was founded by Alfred E. Slanetz in 2015 and is headquartered in Natick, MA. | Commercial Services |
- Borsa valori
- Insiders
- Paul G. Abrams
- Esperienza